Literature DB >> 29514768

Outcome age-based prediction of successful cognitive aging by total cholesterol.

Jeremy M Silverman1, James Schmeidler2.   

Abstract

INTRODUCTION: Some associations of high total cholesterol with dementia risk diminish as the outcome age-age at cognitive assessment-increases.
METHODS: The Framingham Heart Study provided 1897 participants with intact cognition at entry. Cox regression analysis for incident marked cognitive decline included "time-dependent" coefficients, with associations between total cholesterol and covariates changing by outcome age. Decline within age categories of 75-84 and 85-94 years was also examined.
RESULTS: Significant associations of rising total cholesterol linear slope, low entry age, low education, and statin nonuse with risk diminished significantly by outcome age. At 85-94 years, falling linear slope was significant. DISCUSSION: The protected survival model posits a minority subpopulation with protection against mortality and cognitive decline associated with total cholesterol risk factors. It predicts the observed diminished or reversed cholesterol associations with increasing age. Protection is particularly likely for successful cognitive aging-intact cognition at very old age-despite increased risk from cholesterol. Published by Elsevier Inc.

Entities:  

Keywords:  Dementia; Oldest-old; Protected survivor; Protective factors; Risk factors; Survival analysis; Time-dependent coefficients

Mesh:

Substances:

Year:  2018        PMID: 29514768      PMCID: PMC6050071          DOI: 10.1016/j.jalz.2018.01.009

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  27 in total

Review 1.  The effects of cholesterol on learning and memory.

Authors:  Bernard G Schreurs
Journal:  Neurosci Biobehav Rev       Date:  2010-05-12       Impact factor: 8.989

2.  Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.

Authors:  G Li; J B Shofer; W A Kukull; E R Peskind; D W Tsuang; J C S Breitner; W McCormick; J D Bowen; L Teri; G D Schellenberg; E B Larson
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

3.  Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.

Authors:  I L Notkola; R Sulkava; J Pekkanen; T Erkinjuntti; C Ehnholm; P Kivinen; J Tuomilehto; A Nissinen
Journal:  Neuroepidemiology       Date:  1998       Impact factor: 3.282

4.  Impact of plasma lipids and time on memory performance in healthy elderly without dementia.

Authors:  C Reitz; J Luchsinger; M-X Tang; J Manly; R Mayeux
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

5.  Vascular risk factors, incidence of MCI, and rates of progression to dementia.

Authors:  V Solfrizzi; F Panza; A M Colacicco; A D'Introno; C Capurso; F Torres; F Grigoletto; S Maggi; A Del Parigi; E M Reiman; R J Caselli; E Scafato; G Farchi; A Capurso
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

6.  Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis.

Authors:  P W Wilson; J M Hoeg; R B D'Agostino; H Silbershatz; A M Belanger; H Poehlmann; D O'Leary; P A Wolf
Journal:  N Engl J Med       Date:  1997-08-21       Impact factor: 91.245

7.  High total cholesterol levels in late life associated with a reduced risk of dementia.

Authors:  M M Mielke; P P Zandi; M Sjögren; D Gustafson; S Ostling; B Steen; I Skoog
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

8.  The 32-year relationship between cholesterol and dementia from midlife to late life.

Authors:  M M Mielke; P P Zandi; H Shao; M Waern; S Östling; X Guo; C Björkelund; L Lissner; I Skoog; D R Gustafson
Journal:  Neurology       Date:  2010-11-10       Impact factor: 9.910

9.  Determinants of change in total cholesterol and HDL-C with age: the Framingham Study.

Authors:  P W Wilson; K M Anderson; T Harris; W B Kannel; W P Castelli
Journal:  J Gerontol       Date:  1994-11

10.  Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Authors:  Zaldy Sy Tan; Sudha Seshadri; Alexa Beiser; Peter W F Wilson; Douglas P Kiel; Michael Tocco; Ralph B D'Agostino; Philip A Wolf
Journal:  Arch Intern Med       Date:  2003-05-12
View more
  1 in total

1.  Associations of hemoglobin A1c with cognition reduced for long diabetes duration.

Authors:  Jeremy M Silverman; James Schmeidler; Pearl G Lee; Neil B Alexander; Michal Schnaider Beeri; Elizabeth Guerrero-Berroa; Rebecca K West; Mary Sano; Martina Nabozny; Carolina Rodriguez Alvarez
Journal:  Alzheimers Dement (N Y)       Date:  2019-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.